New drug ICP-332 tested in healthy people for safety first
Knowledge-focused
Completed
This early-phase study tested the safety and tolerability of a new drug called ICP-332 in 24 healthy adults aged 18 to 55. Participants received either the drug or a placebo, and researchers monitored for side effects and changes in vital signs, lab values, and heart activity. Th…
Phase: PHASE1 • Sponsor: InnoCare Pharma Inc. • Aim: Knowledge-focused
Last updated May 09, 2026 15:27 UTC